Advances in locoregional therapy for hepatocellular carcinoma combined with immunotherapy and targeted therapy

Advances in locoregional therapy for hepatocellular carcinoma combined with immunotherapy and targeted therapy

Locoregional therapies (LRTs) of hepatocellular carcinoma (HCC) represented by ablation and TACE has become the main means for the clinical treatment of unresectable HCC. Among these, TACE is used throughout the stage Ib to IIIb of HCC treatment. In recent years, immunotherapy led by immune checkpoi...

Full description

Bibliographic Details
Main Authors: Jian Xue, Hongbo Ni, Fan Wang, Ke Xu, Meng Niu
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2021-08-01
Series:Journal of Interventional Medicine
Subjects:
Hepatocellular carcinoma
Locoregional therapy
Immunotherapy
Targeted therapy
Combination therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2096360221000302

Similar Items

Similar Items